DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Anthrax vaccines
Anthrax vaccines
ALTIMMUNE, INC. (Exact Name of Registrant As Specified in Its Charter)
Immune Effector Mechanisms and Designer Vaccines Stewart Sell Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY, USA
Trends in Vaccine Availability and Novel Vaccine Delivery Technologies: 2008–2025
Dissemination of Vaccine Misinformation on Twitter and Its Countermeasures
ACIP Meeting Agenda June 2018
The Jordan Report 20Th Anniversary: Accelerated Development Of
Antibodies to Squalene in Recipients of Anthrax Vaccine
The Anthrax Vaccine Debate: a Medical Review for Commanders
Read More in the Full State of the National Vaccine Plan 2013 Annual
NSIAD-99-5 Gulf War Illnesses: Questions About the Presence Of
T-NSIAD-99-226 Medical Readiness: Issues Concerning the Anthrax
Vaccines for Neglected and Emerging Diseases in Brazil by 2030: the “Valley of Death” and Opportunities for RD&I in Vaccinology 4.0
(Nitags) and WHO Immunisation-Related Advisory Committees
Artículos Científicos
Meeting Transcript
Niaid Strategic Plan for Research on Vaccine Adjuvants
Challenges in the Use of Anthrax Vaccine Adsorbed (Ava) in the Pediatric Population As a Component of Post-Exposure Prophylaxis (Pep)
Immunogenicity and Protective Efficacy of a Non-Living
Top View
Use of Anthrax Vaccine in the United States Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
Recent Developments in the Understanding and Use of Anthrax Vaccine Adsorbed: Achieving More with Less
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
The Annual Report of the State of the National Vaccine Plan
MEDICAL READINESS Safety and Efficacy of the Anthrax Vaccine
Annual Report Dear Fellow Shareholders
Smallpox – Pathology and Clinical Features Alasdair Geddes, University of Birmingham, UK
2016 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan TABLE of CONTENTS EXECUTIVE SUMMARY
Development of a Highly Efficacious Vaccinia-Based Dual
January 2021
Advisory Committee on Immunization Practices (ACIP)
ACIP Meeting Minutes October 24-25 2007
United States District Court District of Maryland Southern Division
Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward
Information Sheet Observed Rate of Vaccine Reactions
Construction of a Bivalent Vaccine Against Anthrax and Smallpox Using the Attenuated Vaccinia Virus KVAC103
Immunization Newsletter
2008 Draft Strategic National Vaccine Plan